Comparison of BMP-2 and combined IGF-I/TGF-β1 application in a sheep cervical spine fusion model

European Spine Journal

Volumn 11, Issue 5, 2002, Pages 482-493

  Kandziora, F ^a   Pflugmacher, R ^a   Scholz, M ^a   Knispel, C ^a   Hiller, T ^a   Schollmeier, G ^a   Bail, H ^a   Schmidmaier, G ^a   Duda, G ^a   Raschke, M ^a   Haas, N ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Animal model; BMP 2; Cervical spine; Growth factor; IGF I; Interbody fusion; Sheep; TGF 1

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; ESCULIN; FLUOROCHROME; SOMATOMEDIN C; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BLOOD SAMPLING; BODY WEIGHT; BONE GRAFT; BONE MATRIX; BONE MINERAL; CALLUS; CANCELLOUS BONE; CERVICAL SPINE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; ILIAC CREST; INTERVERTEBRAL DISKECTOMY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RADIOGRAPHY; SHEEP; TEMPERATURE;

ANIMALS; BLOOD CELL COUNT; BODY WEIGHT; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; CERVICAL VERTEBRAE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; INSULIN-LIKE GROWTH FACTOR I; INTERNAL FIXATORS; MODELS, ANIMAL; OSTEOGENESIS; POSTOPERATIVE COMPLICATIONS; RANGE OF MOTION, ARTICULAR; SHEEP; SPINAL FUSION; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WOUND HEALING;

EID: 0036032292     PISSN: 09406719     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00586-001-0384-4     Document Type: Article

References (46)

1. Ammann P, Bourrin S, Bonjour JP, Meyer JM, Rizzoli R (2000) Protein undernutrition-induced bone loss is associated with decreased IGF-I levels and oestrogen deficiency. J Bone Miner Res 15:683-690
2. Aspenberg P, Turek T (1996) BMP-2 for intramuscular bone induction. Effect in squirrel monkeys is dependent on implantation site. Acta Orthop Scand 67:3-6
3. Beck L, Amento E, Xu Y, Deguzman L, Lee W, Nguyen T, Gillet N (1993) TGF-beta 1 induces bone closure of skull defects - Temporal dynamics of bone formation in defects exposed to rhTGF-beta 1. J Bone Miner Res 8:753-761
4. Boden SD, Martin GJ Jr, Horton WC, Truss TL, Sandhu HS (1998) Laproscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 11:95-101
5. Boden SD, Martin GJ Jr, Morone MA, Ugbo JL, Moskovitz PA (1999) Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 24:1179-1185
6. Boden SD, Zdeblick TA, Sandhu HS, Heim SE (2000) The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report. Spine 25:376-381
7. David SM, Gruber HE, Mayer RA Jr, Murakami T, Tabor OB, Howard BA, Wozney JM, Hanley EN Jr (1999) Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers. Spine 24:1973-1979
8. Fischgrund JS, James SB, Chabot MC, Hankin R, Herkowitz HN, Wozney JM, Shirkhoda A (1997) Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord 10:467-472
9. Fujimoto A, Tanizawa T, Nishida S, Yamamoto N, Soshi S, Endo N, Takahashi HE (1999) Local effects of transforming growth factor-beta 1 on rat calvaria: Changes depending on the dose and the injection site. J Bone Miner Metab 17:11-17
10. Grauer JN, Patel TC, Erulkar JS, Troiano NW, Panjabi MM, Friedlaender GE (2001) 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 26:127-133
11. Hecht BP, Fischgrund JS, Herkowitz HN, Penman L, Toth JM, Shirkhoda A (1999) The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine 24:629-636
12. Hermann R, Schmidmaier G, Markl B, Resch A, Hahnel I, Stemberger A, Alt E (1999) Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 82:51-57
13. Hock J, Centrella M, Canalis E (1988) Insulin like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254-260
14. Hoshi K, Amizuka N, Sakou T, Kurokawa T, Ozawa H (1997) Fibroblasts of spinal ligaments pathologically differentiate into chondrocytes induced by recombinant human bone morphogenetic protein-2: Morphological examinations for ossification of spinal ligaments. Bone 21:155-162
15. Isgaard J, Nilson A, Lindahl A, Jansson J, Isaksson O (1986) Effects of local administration of GH and IGF-I on longitudinal bone growth in rats. Am J Physiol 250:367-372
16. Itoh H, Ebara S, Kamimura M, Tateiwa Y, Kinoshita T, Yuzawa Y, Takaoka K (1999) Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 24:1402-1405
17. Kandziora F, Kerschbaumer F, Starker M, Mittlmeier T (2000) Biomechanical assessment of transoral plate fixation for atlantoaxial instability. Spine 25:1555-1561
18. Kandziora F, Pflugmacher R, Scholz M, Schnake K, Schröder R, Mittlmeier T (2001) Comparison between sheep and human cervical spines: An anatomic, radiographic, bone mineral density, and biomechanical study. Spine 26:1028-1037
19. Kandziora F, Pflugmacher R, Schäfer J, Duda G, Haas NP, Mittlmeier T (2001) Biomechanical comparison of cervical spine interbody fusion cages. Spine 26:1850-1857
20. Kandziora F, Schmidmaier G, Schollmeier G, Bail H, Pflugmacher R, Görke T, Wagner M, Raschke M, Mittlmeier T, Haas NP (2002) IGF-I and TGF-β1 application by a poly-(D,L-lactide) coated interbody cage promotes fusion in the sheep cervical spine. Spine 27 (in press)
21. Kleemann R (1999) Entwicklung eines Wirbelsäulenprüfstands zur Testung von Implantaten an der Halswirbelsäule. Semesterarbeit. Fakultät für Maschinenbau, Technische Universität Berlin
22. Kon T, Yamazaki M, Tagawa M, Goto S, Terakado A, Moriya H, Fujimura S (1997) Bone morphogenetic protein-2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudinal ligament. Calcif Tissue Int 60:291-296
23. Laursen M, Hoy K, Hansen ES, Gelineck J, Christensen FB, Bunger CE (1999) Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: Preliminary results. Eur Spine J 8:485-490
24. Lind M (1998) Growth factor stimulation on bone healing. Effects on osteoblasts, osteotomies, and implants fixations. Acta Orthop Scand Suppl 283:2-37
25. Lind M, Schuhmacker B, Soballe K, Keller J, Melson F, Bunger C (1993) Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthop Scand 64:553-556
26. Martin GJ Jr, Boden SD, Marone MA, Marone MA, Moskovitz PA (1999) Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: Important lessons learned regarding dose, carrier, and safety. J Spinal Disord 12:179-186
27. Meyer RA Jr, Gruber HE, Howard BA, Tabor OB Jr, Murakami T, Kwiatkowski TC, Wozney JM, Hanley EN Jr (1999) Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog. Spine 24:747-754
28. Mimatsu K, Kishi S, Hashizume Y (1997) Experimental chronic compression on the spinal cord of the rabbit by ectopic bone formation in the ligamantum flavum with bone morphogenetic protein. Spinal Cord 35:740-746
29. Mohan S, Baylink D (1991) Bone growth factors. Clin Orthop 263:30-48
30. Nielson H, Isgaard J, Lindahl A, Peterson L, Isaksson O (1987) Effects of unilateral arterial infusion of GH and IGF-I on tibial longitudinal bone growth in hypophysectomized rats. Calcif Tissue Int 40:91-96
31. Pfeilschifter J, Oechsner M, Naumann A, Gronwald R, Minne H, Ziegler R (1990) Stimulation of bone matrix apposition in vitro by local growth factors: A comparison between insulin-like growth factor I, platelet derived growth factor and transforming growth factor beta. Endocrinology 127:69-75
32. Roberts A, Sporn M, Bolander M (1990) Transforming growth factor- beta and the initiation of chondrogenesis in the rat femur. J Cell Biol 110:2195-2207
33. Sandhu HS, Kanim LE, Kabo JM, Toth JM, Zeegen EN, Liu D, Delamater RB, Dawson EG (1996) Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 21:2115-2122
34. Sandhu HS, Kanim LE, Toth JM, Kabo JM, Liu D, Delamarter RB, Dawson EG (1997) Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine 22:1171-1180
35. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M (2001) Biodegradable poly-(D,L-lactide) coating of implants for continuous release of growth factors. J Biomed Mat Res 58:449-455
36. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M (2001) Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone 28:341-350
37. Slappey G, Toribatake Y, Ganey TM, Odgen JA, Hutton WC (1998) Guidelines to decortication in posterolateral spine fusion. J Spinal Disord 11:102-109
38. Steinbrech DS, Mehrara BJ, Rowe NM, Dudziak ME, Luchs JS, Saadeh PB, Gittes GK, Longaker MT (2000) Gene expression of TGF-beta, TGF-beta receptor, and extracellular matrix proteins during membranous bone healing in rats. Plast Reconstr Surg 105:2028-2038
39. Terrell TG, Working PK, Chow CP, Green JD (1993) Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits. Int Rev Exp Pathol 34B:43-67
40. Thaller S, Hoyt J, Tesluck H, Holmes R (1993) The effect of insulin growth factor-I on calvarial sutures in Sprague-Dawley rat. J Craniofac Surg 4:35-39
41. Trippel S, Coutts R, Einhorn T, Mundy R, Rosenfeld R (1996) Growth factors as therapeutic agents. J Bone Joint Surg Am 78:1272-1286
42. Urist MR (1965) Bone: Formation by autoinduction. Science 150:893-899
43. Wilton P (1992) Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on insulin-like growth factor I treatment in growth hormone insensitivity syndromes. Acta Paediatr Suppl 383:137-142
44. Yamada Y, Harada A, Hosoi T, Miyauchi A, Ikeda K, Otha H, Shiraki M (2000) Association of transforming growth factor beta 1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis. J Bone Miner Res 15:415-420
45. Zdeblick TS, Ganayem AJ, Rapoff AJ, Swain C, Bassett T, Cooke ME, Markel M (1998) Cervical interbody fusion cages. An animal model with and without bone morphogenetic protein. Spine 23:758-765
46. Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO (1997) Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 79:1778-1790